Petros Pharmaceuticals, Inc.
PTPI
Rank in Stocks
#33866
Petros Pharmaceuticals, Inc. is a pharmaceutical company dedicated to male... Petros Pharmaceuticals, Inc. is a pharmaceutical company dedicated to male health solutions. Their activities include both the commercialization and ongoing development of Stendra, a prescription PDE-5 inhibitor specifically designed for treating erectile dysfunction (ED). Furthermore, Petros is advancing H100, a proprietary topical formulation currently in development as a potential treatment for acute Peyronie's disease. The company's offerings also extend to a range of erectile dysfunction products, such as vacuum erection devices. Petros Pharmaceuticals, Inc. operates from its base in New York, New York.
Share Price
$0.00325
Last synced: 2026-11-09
Market Cap
$137.71K
Change (1 day)
8.33%
Change (1 year)
-80.88%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Petros Pharmaceuticals, Inc. (PTPI)
Category
Healthcare
Operating Margin for Petros Pharmaceuticals, Inc. (PTPI)
Operating Margin as of November 2026 TTM: 0.00%
According to Petros Pharmaceuticals, Inc.'s latest financial reports, its current operating margin (TTM) is 0.00%. At the end of 2025 the company had an operating margin of 0.00%.
Operating Margin history for Petros Pharmaceuticals, Inc. from 2018 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 0.00% | 0.00% |
| 2025 | 0.00% | -100.00% |
| 2024 | -345.84% | 47.87% |
| 2023 | -233.88% | -29.63% |
| 2022 | -332.37% | 43.85% |
| 2021 | -231.05% | 27.81% |
| 2020 | -180.78% | 45.81% |
| 2019 | -123.98% | 127.70% |
| 2018 | -54.45% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 19.41% | - |
DE
|
|
| 19.68% | - |
DE
|
|
| 13.26% | - |
JP
|
|
| 17.08% | - |
CH
|
|
| 14.92% | - |
IL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Petros Pharmaceuticals, Inc.'s operating margin
What was Petros Pharmaceuticals, Inc.'s operating margin in 2025?
In 2025, Petros Pharmaceuticals, Inc.'s operating margin was 0.00%, compared with -345.84% in 2024.
How has Petros Pharmaceuticals, Inc.'s operating margin changed since 2020?
From 2020 to 2025, Petros Pharmaceuticals, Inc.'s operating margin was highest in 2025 (0.00%) and lowest in 2024 (-345.84%).
How does Petros Pharmaceuticals, Inc.'s operating margin compare with similar companies?
Petros Pharmaceuticals, Inc.'s operating margin (0.00%) is lower than that of all 5 similar companies listed above. The highest among them is Merck KGaA, with 19.68%.